Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Leukemia

  Free Subscription


21.04.2020

1 Am J Clin Oncol
2 Am J Hematol
1 Ann Hematol
1 Biochem Biophys Res Commun
4 Blood
1 Bone Marrow Transplant
1 Eur J Haematol
1 Exp Cell Res
1 Exp Hematol
1 Int J Hematol
1 J Clin Oncol
1 J Pediatr Hematol Oncol
2 Leuk Lymphoma
2 Leukemia
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Oncol

  1. PHUAR HL, Begley CE, Chan W, Krause TM, et al
    Tyrosine Kinase Inhibitors and the Relationship With Adherence, Costs, and Health Care Utilization in Commercially Insured Patients With Newly Diagnosed Chronic Myeloid Leukemia: A Retrospective Claims-Based Study.
    Am J Clin Oncol. 2020 Apr 16. doi: 10.1097/COC.0000000000000700.
    PubMed         Abstract available


    Am J Hematol

  2. MAFFINI E, Labopin M, Blaise D, Ciceri F, et al
    CD34+ cell dose effects on clinical outcomes after T-cell replete haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using peripheral blood stem cells. A Study from the Acute Leukemia Working Party of the Euro
    Am J Hematol. 2020 Apr 17. doi: 10.1002/ajh.25826.
    PubMed         Abstract available

  3. BARON F, Efficace F, Cannella L, Muus P, et al
    Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukemia: Long-term follow up of a phase III study.
    Am J Hematol. 2020 Mar 31. doi: 10.1002/ajh.25795.
    PubMed         Abstract available


    Ann Hematol

  4. GUPTA C, Kaulfuss S, Gorlich K, Othman B, et al
    Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia.
    Ann Hematol. 2020 Apr 15. pii: 10.1007/s00277-020-04001.
    PubMed        


    Biochem Biophys Res Commun

  5. WANG G, Li S, Xue K, Dong S, et al
    PFKFB4 is critical for the survival of acute monocytic leukemia cells.
    Biochem Biophys Res Commun. 2020 Apr 13. pii: S0006-291X(20)30672.
    PubMed         Abstract available


    Blood

  6. MORSCIO J, Van Vlierberghe P
    Chemotherapy at the wheel of ALL relapse.
    Blood. 2020;135:4-5.
    PubMed        

  7. HALE DA, Krause JR
    Unexpected lymph node finding in a patient with essential thrombocythemia.
    Blood. 2020;135:154.
    PubMed        

  8. MEYER SE
    MicroRNA immunomodulating therapeutics.
    Blood. 2020;135:155-156.
    PubMed        

  9. PATNAIK MM, Sallman DA, Mangaonkar A, Heuer R, et al
    Phase 1 study of lenzilumab, a recombinant anti-human GM-CSF antibody, for chronic myelomonocytic leukemia (CMML).
    Blood. 2020 Apr 15. pii: 454390. doi: 10.1182/blood.2019004352.
    PubMed        


    Bone Marrow Transplant

  10. TOMIZAWA D, Yoshida M, Kondo T, Miyamura T, et al
    Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive cases.
    Bone Marrow Transplant. 2018 Jun 29. pii: 10.1038/s41409-018-0273.
    PubMed         Abstract available


    Eur J Haematol

  11. THIELEN FW, van Dongen-Leunis A, Arons A, Ladestein JR, et al
    Cost-Effectiveness of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-cell acute Lymphoblastic Leukemia.
    Eur J Haematol. 2020 Apr 14. doi: 10.1111/ejh.13427.
    PubMed         Abstract available


    Exp Cell Res

  12. RASHID A, Wang R, Zhang L, Yue J, et al
    Dissecting the novel partners of nuclear c-Raf and its role in all-trans retinoic acid (ATRA)-induced myeloblastic leukemia cells differentiation.
    Exp Cell Res. 2020 Apr 10:111989. doi: 10.1016/j.yexcr.2020.111989.
    PubMed         Abstract available


    Exp Hematol

  13. RAZ O, Granot G, Pasmanik-Chor M, Raanani P, et al
    Profiling and Bioinformatics Analyses Reveal Chronic Lymphocytic Leukemia Cells Share a Unique Circular RNA Expression Pattern.
    Exp Hematol. 2020 Apr 10. pii: S0301-472X(20)30137.
    PubMed         Abstract available


    Int J Hematol

  14. OKAMOTO S, Ureshino H, Kawaguchi A, Miyazono M, et al
    Assessment of estimated glomerular filtration rate in patients with chronic myeloid leukemia following discontinuation of tyrosine kinase inhibitors.
    Int J Hematol. 2020 Apr 18. pii: 10.1007/s12185-020-02880.
    PubMed         Abstract available


    J Clin Oncol

  15. FREY NV, Gill S, Hexner EO, Schuster S, et al
    Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2020 Apr 16:JCO1903237. doi: 10.1200/JCO.19.03237.
    PubMed         Abstract available


    J Pediatr Hematol Oncol

  16. KELAIDI C, Makis A, Petrikkos L, Antoniadi K, et al
    Bone Marrow Failure in Fanconi Anemia: Clinical and Genetic Spectrum in a Cohort of 20 Pediatric Patients.
    J Pediatr Hematol Oncol. 2019 Jun 27. doi: 10.1097/MPH.0000000000001549.
    PubMed         Abstract available


    Leuk Lymphoma

  17. RAMALINGAM TR, Muthu A, Vaidhyanathan L, Ramakrishnan B, et al
    Immunophenotypic modulation in pediatric B lymphoblastic leukemia and its implications in MRD detection.
    Leuk Lymphoma. 2020 Apr 12:1-7. doi: 10.1080/10428194.2020.1742902.
    PubMed         Abstract available

  18. STAHL M, Tallman MS
    Late and very late relapses in acute myeloid leukemia (AML).
    Leuk Lymphoma. 2020 Apr 14:1-2. doi: 10.1080/10428194.2020.1745204.
    PubMed        


    Leukemia

  19. ELSAYED AH, Rafiee R, Cao X, Raimondi S, et al
    Correction: A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia.
    Leukemia. 2020 Apr 16. pii: 10.1038/s41375-020-0822.
    PubMed         Abstract available

  20. GENTILE M, Morabito F, Del Poeta G, Mauro FR, et al
    Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study.
    Leukemia. 2020 Apr 14. pii: 10.1038/s41375-020-0833.
    PubMed        


    PLoS One

  21. AGUILERA-DIAZ A, Vazquez I, Ariceta B, Manu A, et al
    Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.
    PLoS One. 2020;15:e0227986.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: